SynthesisPeerJ2026
Effects of cardiac rehabilitation on atrial fibrillation recurrence, mortality, hospitalization, and exercise capacity: a systematic review and meta-analysis.
Synthesis in PeerJ, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Cardiac rehabilitation (CR) may benefit patients with atrial fibrillation (AF) in areas such as exercise capacity. However, evidence regarding its impact on AF recurrence, a key clinical outcome, remains inconsistent. This systematic review and meta-analysis of randomized controlled trials (RCTs) aimed to evaluate the effects of CR on AF recurrence, all-cause mortality, hospitalization, and exercise capacity in patients with AF. Methods: We systematically searched the Cochrane Library, PubMed, and Embase from January 1, 1980, to April 20, 2026. Two reviewers independently screened studies, extracted data, and assessed risk of bias. A total of 1,550 patients from 11 RCTs were included in the meta-analysis based on the predefined inclusion and exclusion criteria. Results: Pooled analysis demonstrated a significant reduction in AF recurrence among patients receiving CR compared with controls (risk ratio (RR) 0.77, 95% confidence interval (CI) [0.67-0.89], Conclusions: CR is associated with a reduction in AF recurrence in the overall AF population, though this benefit was not observed in the exploratory subgroup of patients post-ablation. It significantly improves exercise capacity but does not appear to affect mortality or hospitalization rates. Further high-quality randomized trials are needed to evaluate the benefits and potential risks of CR across different types of AF.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.